Artemis Medicare Services Ltd
Artemis Medicare Services Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #14 of 33 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Artemis Medicare Services Ltd Q2 FY27 key numbers
- Revenue
- Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY.
As stated in Artemis Medicare Services Ltd's Q2 FY27 investor presentation · published 30 Oct 2026. Reported figures, not investment advice.
Based on Artemis Medicare Services Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Q2 FY27 Financials (Consolidated): - EBITDA: INR 6,289 Lacs, up 7.9% YoY - EBITDA Margin: 20.2%, down from 21.2% YoY - PAT: INR 3,110 Lacs, up 3.7% YoY - PAT Margin: 10.0%, down from
From Artemis Medicare Services Ltd's Q2 FY27 earnings-call transcript · updated 30 Oct 2026.
Revenue & Sales Performance
- Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20).
- Q2 FY27 standalone revenue from operations: INR 30,571 Lacs, up 13.3% YoY (Page 38).
- Gurgaon hospital revenue Q2 FY27: INR 29,844 Lacs, up 14.5% YoY (Page 19, 9).
- Q2 FY27 IP (In-Patient) volume: 9,787, increased 12.0% YoY (Page 19).
- ARPOB (Average Revenue Per Occupied Bed) increased 6.6% YoY to INR 86,631 (Page 19).
2 more points from Artemis Medicare Services Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Artemis Medicare Services Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- South Delhi Hospital:
- Planned 650+ beds tertiary & quaternary care facility on ~3.5 acres leased land.
- Capital-efficient 30-year operating agreement enabling asset-light growth.
- Expected operational date: Q4 FY29 / FY30.
- Strengthens premium Delhi NCR healthcare presence.
- Gurgaon Hospital Capacity Expansion:
- 15% increase in FAR with additional FAR purchase to 2.15.
- Adds ~250+ beds, raising capacity to 950–1,000 beds.
- Currently 700 beds operational after third tower opening.
- Raipur Hospital:
- 300+ bed super speciality hospital operational since July 2026.
- Mauritius Facilities:
- 110-bed Artemis Cascavelle Hospital operational FY27.
- 80-bed Artemis Curepipe Hospital (O&M agreement) operational since FY24.
2 more points from Artemis Medicare Services Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Artemis Medicare Services Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Artemis Medicare Services Ltd said on order book & pipeline — free account, 30 seconds.
Artemis Medicare Services Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹306 Cr, net profit ₹31 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Artemis Medicare Services Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio
- Indegene Ltd (Q2 FY27)
Revenue from operations for Q2 FY27: INR 11,223 million, up 39.5% YoY (Page 23, 15, 4) . Key investor presentation takeaways from Indegene Ltd's Q2 FY27 investo
- Aatmaj Healthcare Ltd (Q2 FY27)
Revenue from operations for H1 FY 26-27: ₹1,695.98 million vs ₹1,081.04 million in H1 FY 25-26, reflecting a 54% growth (Page 13 & 14). Key investor presentatio
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Artemis Medicare Services Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Artemis Medicare Services Ltd Q2 FY27 results?
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Q2 FY27 Financials (Consolidated): - EBITDA: INR 6,289 Lacs, up 7.9% YoY - EBITDA Margin: 20.2%, down from 21.2% YoY - PAT: INR 3,110 Lacs, up 3.7% YoY - PAT Margin: 10.0%, down from
What is Artemis Medicare Services Ltd share price analysis?
Artemis Medicare Services Ltd currently shows a neutral. The stock trades at a P/E of 40.9 with a market cap of ₹4,722 Cr. Investors should review the full earnings analysis for detailed insights.
Is Artemis Medicare Services Ltd planning capital expenditure?
South Delhi Hospital: - Planned 650+ beds tertiary & quaternary care facility on ~3.5 acres leased land.
Keep Artemis Medicare Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.